Literature DB >> 18052975

Epileptiform synchronization in the rat insular and perirhinal cortices in vitro.

Jessica R Sudbury1, Massimo Avoli.   

Abstract

The hippocampus plays a primary role in temporal lobe epilepsy, a common form of partial epilepsy in adults. Recent studies, however, indicate that extrahippocampal areas such as the perirhinal and insular cortices represent important participants in this epileptic disorder. By employing field potential recordings in the in vitro 4-aminopyridine model of temporal lobe epilepsy, we have investigated here the contribution of glutamatergic and GABAergic signaling to epileptiform activity in these structures. First, we provide evidence of epileptiform synchronicity between the perirhinal and insular cortices, and resolve some pharmacological and network mechanisms involved in sustaining the interictal- and ictal-like discharges recorded there. Second, we report that in the absence of ionotropic glutamatergic transmission, GABAergic networks produce synchronous potentials that spread between the perirhinal and insular cortices. Finally, we have established that such activity is modulated by activating micro-opioid receptors. Our findings support clinical and experimental evidence concerning the involvement of the perirhinal and insular cortex networks in temporal lobe epilepsy, and provide observations that may impact research focussing on the role of the insular cortex in nociception.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18052975     DOI: 10.1111/j.1460-9568.2007.05962.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  9 in total

1.  Hypersynchronous ictal onset in the perirhinal cortex results from dynamic weakening in inhibition.

Authors:  Rüdiger Köhling; Margherita D'Antuono; Ruba Benini; Philip de Guzman; Massimo Avoli
Journal:  Neurobiol Dis       Date:  2015-12-14       Impact factor: 5.996

2.  Laser-evoked potentials as a tool for assessing the efficacy of antinociceptive drugs.

Authors:  A Truini; G Panuccio; F Galeotti; M R Maluccio; F Sartucci; M Avoli; G Cruccu
Journal:  Eur J Pain       Date:  2009-05-23       Impact factor: 3.931

3.  Early seizures and temporal lobe trauma predict post-traumatic epilepsy: A longitudinal study.

Authors:  Meral A Tubi; Evan Lutkenhoff; Manuel Buitrago Blanco; David McArthur; Pablo Villablanca; Benjamin Ellingson; Ramon Diaz-Arrastia; Paul Van Ness; Courtney Real; Vikesh Shrestha; Jerome Engel; Paul M Vespa
Journal:  Neurobiol Dis       Date:  2018-06-01       Impact factor: 5.996

4.  On the ictogenic properties of the piriform cortex in vitro.

Authors:  Gabriella Panuccio; Gonzalo Sanchez; Maxime Lévesque; Pariya Salami; Marco de Curtis; Massimo Avoli
Journal:  Epilepsia       Date:  2012-03       Impact factor: 5.864

5.  Blockade of in vitro ictogenesis by low-frequency stimulation coincides with increased epileptiform response latency.

Authors:  Toshiyuki Kano; Yuji Inaba; Margherita D'Antuono; Giuseppe Biagini; Maxime Levésque; Massimo Avoli
Journal:  J Neurophysiol       Date:  2015-04-29       Impact factor: 2.714

Review 6.  GABAergic synchronization in the limbic system and its role in the generation of epileptiform activity.

Authors:  Massimo Avoli; Marco de Curtis
Journal:  Prog Neurobiol       Date:  2011-07-23       Impact factor: 11.685

7.  Synchronous GABA-receptor-dependent potentials in limbic areas of the in-vitro isolated adult guinea pig brain.

Authors:  Laura Uva; Massimo Avoli; Marco de Curtis
Journal:  Eur J Neurosci       Date:  2009-03       Impact factor: 3.386

8.  Contribution of GABAergic interneurons to the development of spontaneous activity patterns in cultured neocortical networks.

Authors:  Thomas Baltz; Ana D de Lima; Thomas Voigt
Journal:  Front Cell Neurosci       Date:  2010-06-21       Impact factor: 5.505

Review 9.  Neurosteroids and Focal Epileptic Disorders.

Authors:  Maxime Lévesque; Giuseppe Biagini; Massimo Avoli
Journal:  Int J Mol Sci       Date:  2020-12-10       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.